Pathstone Family Office’s Dentsply Sirona XRAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$332K Buy
+9,711
New +$369K ﹤0.01% 1252
2023
Q1
Sell
-7,180
Closed -$229K 1532
2022
Q4
$229K Buy
+7,180
New +$216K ﹤0.01% 1335
2021
Q1
Sell
-909
Closed -$48K 1365
2020
Q4
$48K Buy
+909
New +$44.8K ﹤0.01% 521

Other funds holding XRAY

Pathstone Family Office's XRAY Position: Q3 2023 in Review

Pathstone Family Office opened a new position in Dentsply Sirona (XRAY) in Q3 2023: 9,711 shares worth $332K. The stake represents ﹤0.01% of the portfolio and ranks #1252 among its holdings. This is a return to the name: Pathstone Family Office previously reported a position in XRAY as recently as Q4 2022.

Pathstone Family Office first reported a position in XRAY in Q4 2020 and has held it in 3 quarters since. 474 funds tracked by Wall St. Rank hold XRAY as of Q3 2023.

  • Pathstone Family Office held 9,711 shares of Dentsply Sirona worth $332K as of Q3 2023.
  • Dentsply Sirona was a new Pathstone Family Office position in Q3 2023.
  • Dentsply Sirona made up ﹤0.01% of Pathstone Family Office's portfolio in Q3 2023, its #1252 holding.
  • Pathstone Family Office first reported a position in Dentsply Sirona in Q4 2020 and has held it in 3 quarters since.
  • 474 funds tracked by Wall St. Rank held Dentsply Sirona as of Q3 2023.

Based on Pathstone Family Office's 13F filing for Q3 2023, filed 8 Nov 2023.